These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10701745)

  • 1. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
    Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):653-9. PubMed ID: 10701745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
    Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
    Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
    Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Suzuki M; Kinashi Y; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1163-70. PubMed ID: 9719128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
    Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
    Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
    Masunaga S; Ono K; Sakurai Y; Suzuki M; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
    Jpn J Cancer Res; 1998 Jan; 89(1):81-8. PubMed ID: 9510480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
    Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
    Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
    Masunaga S; Ono K; Takahashi A; Sakurai Y; Ohnishi K; Kobayashi T; Kinashi Y; Takagaki M; Ohnishi T
    Jpn J Cancer Res; 2002 Dec; 93(12):1366-77. PubMed ID: 12495477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of combination with tirapazamine in boron neutron capture therapy.
    Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
    Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
    Masunaga S; Sakurai Y; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Nagasawa H; Uto Y; Hori H; Ono K
    Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
    Masunaga SI; Sanada Y; Takata T; Tanaka H; Sakurai Y; Suzuki M; Kirihata M; Ono K
    J Radiat Res; 2023 Mar; 64(2):399-411. PubMed ID: 36763853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.